首页> 外文期刊>Frontiers in Cell and Developmental Biology >Brahma Related Gene 1 (Brg1) Regulates Cellular Cholesterol Synthesis by Acting as a Co-factor for SREBP2
【24h】

Brahma Related Gene 1 (Brg1) Regulates Cellular Cholesterol Synthesis by Acting as a Co-factor for SREBP2

机译:Brahma相关基因1(BRG1)通过作为Srebp2的共同因子来调节细胞胆固醇合成

获取原文
获取外文期刊封面目录资料

摘要

Hepatocyte is a hub for cholesterol metabolism. Augmented synthesis of cholesterol in the liver is associated with hypercholesterolemia and contributes to the pathogenesis of a host of cardiovascular and metabolic diseases. Sterol response element binding protein 2 (SREBP2) regulates hepatic cholesterol metabolism by activating the transcription of rate-limiting enzymes in the cholesterol biosynthesis pathway. The underlying epigenetic mechanism is not well understood. We report here that mice with hepatocyte-specific knockout (CKO) of Brg1, a chromatin remodelling protein, exhibit reduced levels of hepatic cholesterol compared to the wild type (WT) littermates when placed on a high-fact diet (HFD) or a methionine-and-choline-deficient diet (MCD). Down-regulation of cholesterol levels as a result of BRG1 deficiency was accompanied by attenuation of cholesterogenic gene transcription. Likewise, BRG1 knockdown in hepatocytes markedly suppressed the induction of cholesterogenic genes by lipid depletion formulas. Brg1 interacted with SREBP2 and was recruited by SREBP2 to the cholesterogenic gene promoters. Reciprocally, Brg1 deficiency dampened the occupancies of SREBP2 on target promoters likely through modulating H3K9 methylation on the cholesterogenic gene promoters. Mechanistically, Brg1 recruits the H3K9 methyltransferase KDM3A to co-regulate pro-cholesterogenic transcription. KDM3A silencing dampened the cholesterogenic response in hepatocytes equivalent to Brg1 deficiency. In conclusion, our data demonstrate a novel epigenetic pathway that contributes to SREBP2-dependent cholesterol synthesis in hepatocytes.
机译:肝细胞是胆固醇代谢的枢纽。肝脏中胆固醇的增强合成与高胆固醇血症有关,有助于一种心血管和代谢疾病的发病机制。甾醇反应元件结合蛋白2(srebp2)通过激活胆固醇生物合成途径中的速率限制酶的转录来调节肝胆胆固醇代谢。潜在的表观遗传机制尚不清楚。我们在此报告,与BRG1的肝细胞特异性敲除(CKO),染色质重塑蛋白,与野生型(WT)凋落物相比,与野生型(HFD)或甲硫氨酸相比,肝胆固醇的肝脏胆固醇的含量降低 - 胆碱缺乏饮食(MCD)。由于BRG1缺乏而导致胆固醇水平的下调伴随着胆固醇基因转录的衰减。同样,BRG1在肝细胞中敲低明显抑制了脂质耗尽式胆固醇基因的诱导。 BRG1与Srebp2相互作用,并由Srebp2募集至胆固醇生成的基因启动子。相互作用的,BRG1缺乏抑制了可能通过调节胆固醇生成基因启动子上的H3K9甲基化的靶促进剂上的Srebp2的占用。机械地,BRG1促进H3K9甲基转移酶KDM3A以共调节促胆固醇发生转录。 KDM3A沉默抑制了与BRG1缺乏相当的肝细胞中的胆固醇反应。总之,我们的数据表明了一种新的表观遗传途径,有助于肝细胞中的Srebp2依赖性胆固醇合成。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号